Track Waters Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Waters Corporation WAT · Stock Open Waters Corporation in new tab

460.25 USD
P/E
192.57
EPS
2.39
P/B
2.96
ROE
1.12
Beta
1.15
Target Price
503.29 USD
Waters Corporation logo

Waters Corporation

🧾 Earnings Recap – Q1 2026

Waters Corporation’s shares gained 15.8% as the company delivered better-than-expected organic growth, strong revenue from newly acquired businesses, and a significant 20% increase in adjusted EPS, reassuring investors on the successful integration and growth prospects.

  • Total revenue reached $1.267 billion, with $747 million organic and $520 million from the Biosciences and Diagnostic Solutions acquisition.
  • Organic revenue grew 13% reported (11% constant currency), surpassing the high end of guidance by ~200 basis points.
  • Biosciences and Diagnostic Solutions combined revenue outperformed guidance by $40 million, with reported growth of 7% since acquisition close.
  • Adjusted EPS rose 20% year-over-year to $2.70, beating the high end of guidance by $0.35.
  • Analytical Sciences delivered 12% organic growth (constant currency), while Advanced Diagnostics and Material Sciences showed mid-single to low-double digit gains despite macro challenges and China-related constraints.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 8, 2027
P/E192.57
EPS2.39
Book Value155.60
Price to Book2.96
Debt/Equity36.07
% Insiders0.578%
Growth
Revenue Growth1.21%
Earnings Growth-0.67%
Estimates
Forward P/E27.85
Forward EPS16.53
Target Mean Price503.29

DCF valuation

Model fair value for Waters Corporation (WAT)
Result
Sign in to run the valuation for WAT.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
23 analysts · consensus Buy · mean target 503.29 USD (low 387.00, high 550.00) · as of 15 Nov 2026
Low 387.00
Mean 503.29
High 550.00
Price 460.25
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Waters Corporation Logo Waters Corporation Analysis (WAT)

United States Health Care Official Website Stock

Is Waters Corporation a good investment? Waters Corporation (WAT) is currently trading at 460.25 USD. Market analysts have a consensus price target of 503.29 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 192.57. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Waters Corporation is expected to release its next earnings report on Feb. 8, 2027. The market consensus estimate for Forward EPS is 16.53.

Investor FAQ

Does Waters Corporation pay a dividend?

No, it does not currently pay a dividend.

What asset class is Waters Corporation?

Waters Corporation is classified as a Stock. You can compare it against 5 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 8, 2027. The company currently has a trailing EPS of 2.39.

Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Exchange Ticker
NYQ (United States) WAT
SAO (Brazil) WATC34.SA
FRA (Germany) WAZ.F
LSE (United Kingdom) 0LTI.L
WAZ.SG
Trades
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸1996
0.16 USD
Nov. 26, 1996 0.1600
Stock Splits
Split Date Split Ratio to 1
June 11, 1999 2:1
Aug. 28, 2000 2:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion